Literature DB >> 9745396

Primary medical therapy for acromegaly.

P U Freda, S L Wardlaw.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9745396     DOI： 10.1210/jcem.83.9.5145

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  3 in total

1.  Cost-of-illness study in acromegalic patients in Italy.

Authors:  G Didoni; S Grottol; V Gasco; M Battistini; D Ferone; M Giusti; F Ragazzoni; P Ruffo; E Ghigo; F Minuto
Journal:  J Endocrinol Invest       Date:  2004-12       Impact factor: 4.256

Review 2.  Novel pituitary ligands: peroxisome proliferator activating receptor-gamma.

Authors:  Anthony P Heaney
Journal:  Pituitary       Date:  2003       Impact factor: 4.107

Review 3.  Somatostatin analogs in medical treatment of acromegaly.

Authors:  Michael S Racine; Ariel L Barkan
Journal:  Endocrine       Date:  2003-04       Impact factor: 3.633
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.